Portfolio (Quarterly)
Guide ↗
PSP Research LLC
· CIK 0002106939| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | PTCT | PTC THERAPEUTICS INC | Healthcare | 6,000.0 | $489K | 0.26% | — | — | $81.57 | -14.1% |
| 22 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 13,000.0 | $484K | 0.26% | — | — | $37.21 | +5.1% |
| 23 | IMCR | IMMUNOCORE HLDGS PLC | Healthcare | 15,141.0 | $481K | 0.26% | — | — | $31.75 | +15.3% |
| 24 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 10,000.0 | $470K | 0.25% | -25K | -71.3% | $47.04 | -12.9% |
| 25 | COGT | COGENT BIOSCIENCES INC | Healthcare | 12,000.0 | $464K | 0.25% | — | — | $38.70 | -10.4% |
| 26 | KYMR | KYMERA THERAPEUTICS INC | Healthcare | 4,000.0 | $459K | 0.24% | -2K | -36.5% | $114.67 | +3.0% |
| 27 | DYN | DYNE THERAPEUTICS INC | Healthcare | 20,000.0 | $444K | 0.24% | — | — | $22.21 | +12.9% |
| 28 | ALNY | ALNYLAM PHARMACEUTICALS INC | Healthcare | 1,465.0 | $441K | 0.23% | — | — | $301.03 | -21.2% |
| 29 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 7,000.0 | $441K | 0.23% | — | — | $62.94 | +14.0% |
| 30 | SNDX | SYNDAX PHARMACEUTICALS INC | Healthcare | 20,000.0 | $437K | 0.23% | — | — | $21.86 | -10.6% |
| 31 | EXEL | EXELIXIS INC | Healthcare | 8,000.0 | $435K | 0.23% | -4K | -33.0% | $54.41 | +0.1% |
| 32 | CRNX | CRINETICS PHARMACEUTICALS IN | Healthcare | 11,000.0 | $412K | 0.22% | — | — | $37.42 | +126.7% |
| 33 | — | NEWAMSTERDAM PHARMA COMPANY | — | 12,000.0 | $407K | 0.22% | -3K | -20.0% | $33.89 | — |
| 34 | — | ASCENDIS PHARMA A/S | — | 1,500.0 | $400K | 0.21% | NEW | — | $266.72 | — |
| 35 | LQDA | LIQUIDIA CORPORATION | Healthcare | 5,000.0 | $399K | 0.21% | NEW | — | $79.73 | -15.1% |
| 36 | STOK | STOKE THERAPEUTICS INC | Healthcare | 12,000.0 | $393K | 0.21% | — | — | $32.72 | -3.4% |
| 37 | VKTX | VIKING THERAPEUTICS INC | Healthcare | 10,000.0 | $390K | 0.21% | -5K | -33.3% | $39.01 | -17.6% |
| 38 | IMNM | IMMUNOME INC | Healthcare | 18,000.0 | $381K | 0.20% | -2K | -10.0% | $21.19 | +30.1% |
| 39 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 3,000.0 | $368K | 0.20% | — | — | $122.58 | +17.7% |
| 40 | HRMY | HARMONY BIOSCIENCES HLDGS IN | Healthcare | 10,000.0 | $364K | 0.19% | -4K | -30.0% | $36.41 | +7.7% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
100.0%